跳至主要内容
临床试验/NCT03575650
NCT03575650招募中不适用

Early Detection of Imaging-derived Subclinical Cardiac Injuries After Radiotherapy and Chemotherapy for Breast Cancer

University Medical Center Groningen1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2019年1月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
148
试验地点
1
主要终点
Left Ventricle Global Longitudinal Strain (LV-GLS) assessed by echocardiography

研究概览

简要总结

Breast cancer (BC) radiotherapy leads to incidental cardiac irradiation, resulting in an increased risk of various major cardiac events (MCEs). In addition, recent studies indicate that for the treatment of BC, the addition of chemotherapy further enhances the risk of MCEs. Information regarding morphological and functional early subclinical cardiac injuries (ESCIs) induced by chemotherapy and radiotherapy that develop into MCEs is largely lacking in scientific literature. This information is essential towards the development of primary and secondary preventive strategies. The EMIRA prospective cohort has as main objective to identify morphological and functional ESCIs in BC patients treated with adjuvant radiotherapy and chemotherapy.

详细描述

EMIRA is a single centre prospective observational cohort study performed in the UMCG. The study includes breast cancer patients that underwent primary surgery, either by mastectomy or breast conserving surgery, who are treated with adjuvant radiotherapy and chemotherapy as part of routine clinical care. The patient follow up time continues for 2 years after radiotherapy to identify early subclinical cardiac injuries (ESCIs), using repeat echocardiography (cECHO), cardiac MRI (cMRI) scans and cardiac CT (cCT) scans. The images are acquired prior to chemotherapy and/or radiotherapy (depending on the sequence of adjuvant treatment), and at 6 and 24 months after radiotherapy The first primary aim of this project is to detect ESCIs that are considered risk factors for clinically apparent major cardiac events in breast cancer patients treated with radiotherapy and chemotherapy. The second is to use this information to develop prediction models describing the relationship between the radiation dose to cardiac substructures and ESCIs.

In detail, the investigators aim to:

  1. identify longitudinal morphological and functional ESCIs using echocardiography, cardiac MRI and cardiac CT before and after BC treatment;
  2. determine the relationship between 3D-dose distributions to cardiac substructures and ESCI;
  3. establish the effect of chemotherapy on the dose-effect relationship between radiation dose and ESCI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female unilateral BC patients
  • Primary breast conserving surgery or mastectomy for stage I-III invasive adenocarcinoma of the breast or ductal carcinoma in situ (DCIS)
  • Age between 40-70 years at time of chemotherapy/radiotherapy
  • WHO performance status 0-1
  • Planned radiotherapy to the breast/chest wall with or without the lymph node areas
  • Radiotherapy based on planning CT-scan, using either 3D CRT, (partial) IMRT or (partial) VMAT/RapidArc with or without deep inspiration breath-hold
  • Adjuvant systemic chemotherapy (before or after radiotherapy)
  • Written informed consent

排除标准

  • Male BC patients
  • M1 disease (metastatic BC)
  • Previous thoracic or mediastinal radiation
  • Neo-adjuvant chemotherapy not allowed
  • Targeted HER2 therapy not allowed
  • Medical history of coronary artery disease and/or myocardial infarction and/or atrial fibrillation
  • Contraindications to injection of iodinated contrast such as allergy or renal failure
  • Pregnancy or lactation
  • Atrial fibrillation detected during electrocardiogram before chemotherapy/radiotherapy
  • Abnormal echocardiography before chemotherapy/radiotherapy defined as: LVEF <50%, longitudinal strain <-16%, longitudinal strain rate <-1%, and/or abnormal wall motion
  • Presence of myocardial infarction detected during cMRI before chemotherapy/radiotherapy
  • cMRI or cCT results before chemotherapy/radiotherapy requiring revascularisation

结局指标

主要结局

Left Ventricle Global Longitudinal Strain (LV-GLS) assessed by echocardiography

时间窗: 6 and 24 months after radiotherapy with reference to baseline

Increasement in left ventricle Global Longitudinal Strain (GLS) of at least 5%

次要结局

  • Changes in myocardial function assessed by echocardiography(6 and 24 after completion of radiotherapy with reference to baseline)
  • Anatomical changes in coronary arteries by cardiac CT(6 and 24 after completion of radiotherapy with reference to baseline)
  • Myocardial tissue abnormalities assessed by cardiac MRI(6 and 24 after completion of radiotherapy with reference to baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验